Leverage the Regulatory Reform in China to Accelerate Global Drug Development Program

Dr. Dan Zhang, Executive Chairman of FMD, will discuss the impact of the recent regulatory reform in China. Among other strategic imperatives, Dr. Zhang will delineate the potentials to leverage these favorable changes to accelerate global drug development programs. Limited space is on a first-come-first-serve basis. Registration is open now.